Skip to main content
Log in

Colchicine induced remission in amyloid nephrotic syndrome

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

An unusual case of reversible reactive amyloidosis (AA) is described. A patient in the course of lobar pneumonia developed acute transient nephrotic syndrome and renal failure. Renal and liver biopsy showed amyloidosis and positive immunohistochemistry stains for amyloid A protein.

The nephrotic syndrome resolved completely following 6 months of colchicine treatment and the urine is protein free after 6 years of follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jones, N.F. Renal amyloidosis: pathogenesis and therapy. Clin Nephrol 1976, 6, 459–464.

    PubMed  Google Scholar 

  2. Falck, H.M., Tornroth, T., Skrifvars, B., et al. Resolution of renal amyloidosis secondary to rheumatoid arthritis Acta Med Scand 1979, 205, 651–656.

    Google Scholar 

  3. Dikman, S.H., Kahn, T., Gribetz, D., et al. Resolution of renal amyloidosis. Am J Med 1977, 63, 430–433.

    PubMed  Google Scholar 

  4. Levy, M., Prieur, A.M., Gubler, M.C., Hayem, F., Manigne, P., Cheron, G., Niaudet, P. Renal involvement in juvenile chronic arthritis: clinical and pathologic features. Am J Kidney Dis 1987, 9, 138–146.

    PubMed  Google Scholar 

  5. Escalante, A., Ehresmann, G.R., Quismorio, F.P. Jr. Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine. Arthritis Rheum 1991, 34, 920–922.

    PubMed  Google Scholar 

  6. Benson, M.D. Treatment of AL amyloidosis with melphalan, prednisone, and colchicine. Arthritis Rheum 1986, 29, 683–687.

    PubMed  Google Scholar 

  7. Gertz, M.A., Kyle, R.A. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 1991, 70, 246–256.

    PubMed  Google Scholar 

  8. Crowley, S., Feinfeld, D.A., Janis, R. Resolution of nephrotic syndrome and lack of progression of heroin-associated renal amyloidosis. Am J Kidney Dis 1989, 13, 333–335.

    PubMed  Google Scholar 

  9. Thysell, H., Ingvar, C., Gustafson, T., Holmin, T. Systemic reactive amyloidosis caused by hepatocellular adenoma. A case report. J Hepatol 1986, 2, 450–457.

    PubMed  Google Scholar 

  10. Deschenes, G., Prieur, A.M., Hayem, F., Broyer, M., Gubler, M.C. Renal amyloidosis in juvenile chronic arthritis: evolution after chlorambucil treatment. Pediatr-Nephrol 1990, 4, 463–469.

    PubMed  Google Scholar 

  11. Short, C.D., Mallick, N.P. Renal manifestations of systemic diseases. The practitioner 1981, 225, 997–1005.

    PubMed  Google Scholar 

  12. Michael, J., Jones, N.F. Spontaneous remission of nephrotic syndrome in renal amyloidosis Br Med J 1978, 1, 1592–1593.

    PubMed  Google Scholar 

  13. Mery, J.P., Mostefa, S. Remission in renal amyloidosis. Ann Intern Med 1975, 83, 581.

    Google Scholar 

  14. Harats, D., Friedlander, M., Koplovic, Y., Friedman, G. Prolonged reversible acute renal failure in focal glomerulonephritis with severe nephrotic syndrome in an elderly patient. Klin Wochenschr 1989, 67, 502–505.

    PubMed  Google Scholar 

  15. Sennesael, J., Van-den-Houte, K., Verbeelen, D. Reversible membranous glomerulonephritis associated with ketoprofen. Clin Nephrol 1986, 26, 213–215.

    PubMed  Google Scholar 

  16. Tang, A.L., Davies, D.R., Wing, A.J. Remission of nephrotic syndrome in amyloidosis associated with a hypernephroma. Clin Nephrol 1989, 32, 225–228.

    PubMed  Google Scholar 

  17. Cusano, A.J., Bland, J.H., Lapenas, D.J., Cohen, A.S., Libbey, C. Juvenile rheumatoid arthritis with renal amyloidosis: a 23-year survival. J Rheumatol 1982, 9(6), 921–925.

    PubMed  Google Scholar 

  18. Gertz, M.A., Kyle, R.A. Secondary systemic amyloidosis: response and survival in 64 patients. Med Baltimore 1991, 70, 246–256.

    Google Scholar 

  19. Zemer, D., Pras, M., Sohar, E. et al. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever (FMF). N Engl J Med 1986, 314, 1001–1005.

    PubMed  Google Scholar 

  20. Ravid, M., Robson, M., Kedar, I. Prolonged colchicine treatment in four patients with amyloidosis. Ann Intern Med 1977, 87, 568–570.

    PubMed  Google Scholar 

  21. Brandwein, S.R., Sipe, J.D., Skinner, M., Cohen, A.S. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation. Lab Invest 1985, 52, 319–325.

    PubMed  Google Scholar 

  22. Rosenthal, C.J., Franklin, B., Greenspan, J. Isolation and partial characterization of SAA — an amyloid related protein from human serum. J Immunol 1976, 116, 1415–1418.

    PubMed  Google Scholar 

  23. McAdam, K.P.W.S., Sipe, J.D. Murine model for secondary amyloidosis. Genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med 1976, 144, 1121–1126.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oren, R., Pizov, G., Naparstek, Y. et al. Colchicine induced remission in amyloid nephrotic syndrome. Clin Rheumatol 12, 532–534 (1993). https://doi.org/10.1007/BF02231786

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02231786

Key words

Navigation